{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:06:31Z","timestamp":1771931191500,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1048740, APP1061332"],"award-info":[{"award-number":["APP1048740, APP1061332"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advanced hepatic fibrosis occurs in up to 25% of individuals with C282Y homozygous hemochromatosis. Our aim was to determine whether human leukocyte antigen (HLA)-A3 and B7 alleles act as genetic modifiers of the likelihood of advanced hepatic fibrosis. Between 1972 and 2013, 133 <jats:italic>HFE<\/jats:italic> C282Y homozygous individuals underwent clinical and biochemical evaluation, HLA typing, liver biopsy for fibrosis staging and phlebotomy treatment. Hepatic fibrosis was graded according to Scheuer as F0\u20132 (low grade hepatic fibrosis), F3\u20134 (advanced hepatic fibrosis), and F4 cirrhosis. We analysed associations between the severity of fibrosis and HLA-A3 homozygosity, heterozygosity or absence, with or without the presence of HLA-B7 using categorical analysis. The mean age of HLA-A3 homozygotes (n\u2009=\u200924), heterozygotes (n\u2009=\u200965) and HLA-A3 null individuals (n\u2009=\u200944) was 40\u00a0years. There were no significant differences between the groups for mean(\u00b1\u2009SEM) serum ferritin levels (1320\u2009\u00b1\u2009296, 1217\u2009\u00b1\u2009124, 1348\u2009\u00b1\u2009188\u00a0<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upmu$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03bc<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>g\/L), hepatic iron concentration (178\u2009\u00b1\u200926, 213\u2009\u00b1\u200922, 199\u2009\u00b1\u200929\u00a0<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upmu$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03bc<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>mol\/g), mobilizable iron stores (9.9\u2009\u00b1\u20091.5, 9.5\u2009\u00b1\u20091.5, 11.5\u2009\u00b1\u20091.7\u00a0g iron removed via phlebotomy), frequency of advanced hepatic fibrosis (5\/24[12%], 13\/63[19%], 10\/42[19%]) or cirrhosis (3\/24[21%], 12\/63[21%], 4\/42[24%]), respectively. The presence or absence of HLA-B7 did not influence the outcome. Thus, HLA-A3 and HLA-B7 alleles are not associated with the risk of advanced hepatic fibrosis or cirrhosis in C282Y hemochromatosis.<\/jats:p>","DOI":"10.1038\/s41598-023-35028-4","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T10:02:28Z","timestamp":1683972148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis"],"prefix":"10.1038","volume":"13","author":[{"given":"John K.","family":"Olynyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise E.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"35028_CR1","doi-asserted-by":"crossref","unstructured":"Girelli, D., Busti, F., Brissot, P., Cabantchik, I., Muckenthaler, M. U., Porto, G. Hemochromatosis Classification: Update and Recommendations by the BIOIRON Society. Blood (2021).","DOI":"10.1182\/blood.2021011338"},{"key":"35028_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","volume":"114","author":"KV Kowdley","year":"2019","unstructured":"Kowdley, K. V., Brown, K. E., Ahn, J. & Sundaram, V. ACG Clinical Guideline: Hereditary Hemochromatosis. Am. J. Gastroenterol. 114, 1202\u20131218 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"35028_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMra2119758","volume":"387","author":"JK Olynyk","year":"2022","unstructured":"Olynyk, J. K. & Ramm, G. A. Hemochromatosis. N. Engl. J. Med. 387, 2159\u20132170 (2022).","journal-title":"N. Engl. J. Med."},{"key":"35028_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa073286","volume":"358","author":"KJ Allen","year":"2008","unstructured":"Allen, K. J. et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358, 221\u2013230 (2008).","journal-title":"N. Engl. J. Med."},{"key":"35028_CR5","doi-asserted-by":"publisher","first-page":"18016","DOI":"10.1038\/nrdp.2018.16","volume":"4","author":"P Brissot","year":"2018","unstructured":"Brissot, P. et al. Haemochromatosis. Nat. Rev. Dis. Prim. 4, 18016 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"35028_CR6","doi-asserted-by":"publisher","first-page":"28494","DOI":"10.1074\/jbc.C600197200","volume":"281","author":"T Goswami","year":"2006","unstructured":"Goswami, T. & Andrews, N. C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 281, 28494\u201328498 (2006).","journal-title":"J. Biol. Chem."},{"key":"35028_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1182\/blood-2018-06-815894","volume":"133","author":"CY Wang","year":"2019","unstructured":"Wang, C. Y. & Babitt, J. L. Liver iron sensing and body iron homeostasis. Blood 133, 18\u201329 (2019).","journal-title":"Blood"},{"key":"35028_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(03)12602-5","volume":"361","author":"KR Bridle","year":"2003","unstructured":"Bridle, K. R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669\u2013673 (2003).","journal-title":"Lancet"},{"key":"35028_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJMoa041534","volume":"352","author":"PC Adams","year":"2005","unstructured":"Adams, P. C. et al. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 352, 1769\u20131778 (2005).","journal-title":"N. Engl. J. Med."},{"key":"35028_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1056\/NEJM199909023411002","volume":"341","author":"JK Olynyk","year":"1999","unstructured":"Olynyk, J. K. et al. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341, 718\u2013724 (1999).","journal-title":"N. Engl. J. Med."},{"key":"35028_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.21037\/atm-20-5512","volume":"9","author":"GJ Anderson","year":"2021","unstructured":"Anderson, G. J. & Bardou-Jacquet, E. Revisiting hemochromatosis: genetic vs phenotypic manifestations. Ann. Transl. Med. 9, 731 (2021).","journal-title":"Ann. Transl. Med."},{"key":"35028_CR12","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1182\/blood-2007-11-122374","volume":"111","author":"MJ Wood","year":"2008","unstructured":"Wood, M. J., Powell, L. W. & Ramm, G. A. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111, 4456\u20134462 (2008).","journal-title":"Blood"},{"key":"35028_CR13","first-page":"1432","volume":"4","author":"M Simon","year":"1975","unstructured":"Simon, M., Pawlotsky, Y., Bourel, M., Fauchet, R. & Genetet, B. Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen. Nouv Presse. Med. 4, 1432 (1975).","journal-title":"Nouv Presse. Med."},{"key":"35028_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/gut.17.5.332","volume":"17","author":"M Simon","year":"1976","unstructured":"Simon, M., Bourel, M., Fauchet, R. & Genetet, B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17, 332\u2013334 (1976).","journal-title":"Gut"},{"key":"35028_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0198-8859(80)90005-1","volume":"1","author":"CQ Edwards","year":"1980","unstructured":"Edwards, C. Q., Cartwright, G. E., Skolnick, M. H. & Amos, D. B. Genetic mapping of the hemochromatosis locus on chromosome six. Hum. Immunol. 1, 19\u201322 (1980).","journal-title":"Hum. Immunol."},{"key":"35028_CR16","first-page":"89","volume":"41","author":"M Simon","year":"1987","unstructured":"Simon, M. et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am. J. Hum. Genet. 41, 89\u2013105 (1987).","journal-title":"Am. J. Hum. Genet."},{"key":"35028_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/bcmd.1996.0100","volume":"22","author":"JC Barton","year":"1996","unstructured":"Barton, J. C., Harmon, L., Rivers, C. & Acton, R. T. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Mol. Dis. 22, 195\u2013204 (1996).","journal-title":"Blood Cells Mol. Dis."},{"key":"35028_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079990","volume":"8","author":"M Costa","year":"2013","unstructured":"Costa, M. et al. Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas. PLoS ONE 8, e79990 (2013).","journal-title":"PLoS ONE"},{"key":"35028_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2350-9-97","volume":"9","author":"E Cruz","year":"2008","unstructured":"Cruz, E. et al. A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med. Genet. 9, 97 (2008).","journal-title":"BMC Med. Genet."},{"key":"35028_CR20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajmg.1320560418","volume":"56","author":"EC Jazwinska","year":"1995","unstructured":"Jazwinska, E. C. et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am. J. Hum. Genet. 56, 428\u2013433 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"35028_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/hep.510240109","volume":"24","author":"A Piperno","year":"1996","unstructured":"Piperno, A. et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 24, 43\u201346 (1996).","journal-title":"Hepatology"},{"key":"35028_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/00365513.2017.1342136","volume":"77","author":"K Thorstensen","year":"2017","unstructured":"Thorstensen, K. et al. Iron loading in HFE p.C282Y homozygotes found by population screening: Relationships to HLA-type and T-lymphocyte subsets. Scand. J. Clin. Lab. Invest. 77, 477\u2013485 (2017).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"35028_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41065-022-00237-w","volume":"159","author":"JC Barton","year":"2022","unstructured":"Barton, J. C., Barton, J. C. & Acton, R. T. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity. Hereditas 159, 25 (2022).","journal-title":"Hereditas"},{"key":"35028_CR24","doi-asserted-by":"publisher","first-page":"20234","DOI":"10.1038\/s41598-019-56732-0","volume":"9","author":"J Chin","year":"2019","unstructured":"Chin, J. et al. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis. Sci. Rep. 9, 20234 (2019).","journal-title":"Sci. Rep."},{"key":"35028_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13, 372\u2013374 (1991).","journal-title":"J. Hepatol."},{"key":"35028_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/hep.27711","volume":"62","author":"CE McLaren","year":"2015","unstructured":"McLaren, C. E. et al. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload. Hepatology 62, 429\u2013439 (2015).","journal-title":"Hepatology"},{"key":"35028_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcmd.2015.04.001","volume":"55","author":"FC Radio","year":"2015","unstructured":"Radio, F. C. et al. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes. Blood Cells Mol. Dis. 55, 71\u201375 (2015).","journal-title":"Blood Cells Mol. Dis."},{"key":"35028_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcmd.2009.10.001","volume":"44","author":"J Milet","year":"2010","unstructured":"Milet, J. et al. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: A follow-up study. Blood Cells Mol. Dis. 44, 34\u201337 (2010).","journal-title":"Blood Cells Mol. Dis."},{"key":"35028_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.vh.2019.01.004","volume":"110","author":"L Silvestri","year":"2019","unstructured":"Silvestri, L., Nai, A., Dulja, A. & Pagani, A. Hepcidin and the BMP-SMAD pathway: An unexpected liaison. Vitam. Horm. 110, 71\u201399 (2019).","journal-title":"Vitam. Horm."},{"issue":"672\u2013683","key":"35028_CR30","volume":"150","author":"R Daher","year":"2016","unstructured":"Daher, R. et al. Heterozygous mutations in BMP6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans. Gastroenterology 150(672\u2013683), e674 (2016).","journal-title":"Gastroenterology"},{"key":"35028_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ajh.24730","volume":"92","author":"C Piubelli","year":"2017","unstructured":"Piubelli, C. et al. Identification of new BMP6 pro-peptide mutations in patients with iron overload. Am. J. Hematol. 92, 562\u2013568 (2017).","journal-title":"Am. J. Hematol."},{"key":"35028_CR32","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1093\/hmg\/ddu076","volume":"23","author":"F Stickel","year":"2014","unstructured":"Stickel, F. et al. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Hum. Mol. Genet. 23, 3883\u20133890 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"35028_CR33","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3748\/wjg.v18.i22.2813","volume":"18","author":"L Valenti","year":"2012","unstructured":"Valenti, L. et al. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. World. J. Gastroenterol. 18, 2813\u20132820 (2012).","journal-title":"World. J. Gastroenterol."},{"key":"35028_CR34","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"35028_CR35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.cgh.2020.07.052","volume":"19","author":"J Chin","year":"2021","unstructured":"Chin, J. et al. Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE. Clin. Gastroenterol. Hepatol. 19, 1459-1468.e1455 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"35028_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-8278(99)80161-5","volume":"31","author":"R Pratiwi","year":"1999","unstructured":"Pratiwi, R. et al. Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. J. Hepatol. 31, 39\u201346 (1999).","journal-title":"J. Hepatol."},{"key":"35028_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1600-0609.2007.00953.x","volume":"79","author":"KS Olsson","year":"2007","unstructured":"Olsson, K. S., Ritter, B. & Hansson, N. The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?. Eur. J. Haematol. 79, 429\u2013434 (2007).","journal-title":"Eur. J. Haematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35028-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T10:04:43Z","timestamp":1683972283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35028-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35028"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35028-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7775"}}